Skip to main content
. 2023 Mar 16;11:1152207. doi: 10.3389/fbioe.2023.1152207

FIGURE 4.

FIGURE 4

MSC-derived secretome enhanced hNPC viability and reduced cell death. The LIVE/DEAD assay showed that both BM-MSCsec and ADSCsec significantly increased cell viability compared to the control group (A). Following IL-1β pretreatment, BM-MSCsec significantly rescued hNPC vitality compared to cells treated with IL-1β alone (B). (C) BM-MSCsec and ADSCsec treatment did not substantially impact on cell death. (D) After IL-1β pretreatment, BM-MSCsec significantly reduced the number of dead cells compared to hNPCs treated with IL-1β alone. Results were normalized to the control group and expressed as percent variation. *p < 0.05, **p < 0.01.